A

ASP Isotopes Inc
NASDAQ:ASPI

Watchlist Manager
ASP Isotopes Inc
NASDAQ:ASPI
Watchlist
Price: 4.48 USD -1.75% Market Closed
Market Cap: 318.8m USD
Have any thoughts about
ASP Isotopes Inc?
Write Note

ASP Isotopes Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ASP Isotopes Inc
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
ASP Isotopes Inc
NASDAQ:ASPI
Cash from Financing Activities
$13.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sherwin-Williams Co
NYSE:SHW
Cash from Financing Activities
-$2B
CAGR 3-Years
11%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
International Flavors & Fragrances Inc
NYSE:IFF
Cash from Financing Activities
-$2B
CAGR 3-Years
-22%
CAGR 5-Years
-45%
CAGR 10-Years
-27%
Dupont De Nemours Inc
NYSE:DD
Cash from Financing Activities
-$2.3B
CAGR 3-Years
35%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Ecolab Inc
NYSE:ECL
Cash from Financing Activities
-$2.1B
CAGR 3-Years
-11%
CAGR 5-Years
-11%
CAGR 10-Years
-6%
PPG Industries Inc
NYSE:PPG
Cash from Financing Activities
-$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
-19%
CAGR 10-Years
3%
No Stocks Found

ASP Isotopes Inc
Glance View

Market Cap
306.5m USD
Industry
Chemicals

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. The company is headquartered in Boca Raton, Florida and currently employs 4 full-time employees. The company went IPO on 2022-11-10. The firm has developed the aerodynamic separation process (ASP technology) for the production, distribution, marketing, and sale of all isotopes. Its technology allows it to enrich elements with both low and high atomic masses. The Company’s focus is on the production and commercialization of enriched Molybdenum-100 (Mo-100). The company also intends to use the ASP technology licensed to produce enriched Uranium-235 (U-235). The company operates principally through subsidiaries: ASP Isotopes Guernsey Limited, which is focused on the development and commercialization of high value, low volume isotopes for specialized end markets (such as Mo-100 and others, including Silicon-28); Enriched Energy LLC, which is focused on the development and commercialization of uranium for the nuclear energy market; and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the exclusive license agreement with Klydon Proprietary Ltd.

ASPI Intrinsic Value
1.92 USD
Overvaluation 57%
Intrinsic Value
Price
A

See Also

What is ASP Isotopes Inc's Cash from Financing Activities?
Cash from Financing Activities
13.4m USD

Based on the financial report for Dec 31, 2023, ASP Isotopes Inc's Cash from Financing Activities amounts to 13.4m USD.

What is ASP Isotopes Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
102%

Over the last year, the Cash from Financing Activities growth was 102%.

Back to Top